190 related articles for article (PubMed ID: 19843405)
1. Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks.
Prematta MJ; Kemp JG; Gibbs JG; Mende C; Rhoads C; Craig TJ
Allergy Asthma Proc; 2009; 30(5):506-11. PubMed ID: 19843405
[TBL] [Abstract][Full Text] [Related]
2. Characterization of prodromal symptoms in a large population of patients with hereditary angio-oedema.
Magerl M; Doumoulakis G; Kalkounou I; Weller K; Church MK; Kreuz W; Maurer M
Clin Exp Dermatol; 2014 Apr; 39(3):298-303. PubMed ID: 24635064
[TBL] [Abstract][Full Text] [Related]
3. Per-attack reporting of prodromal symptoms concurrent with C1-inhibitor treatment of hereditary angioedema attacks.
Prematta MJ; Bewtra AK; Levy RJ; Wasserman RL; Jacobson KW; Machnig T; Craig TJ
Adv Ther; 2012 Oct; 29(10):913-22. PubMed ID: 23054691
[TBL] [Abstract][Full Text] [Related]
4. Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys.
Reshef A; Prematta MJ; Craig TJ
Allergy Asthma Proc; 2013; 34(3):261-6. PubMed ID: 23676575
[TBL] [Abstract][Full Text] [Related]
5. Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review.
Kemp JG; Craig TJ
Allergy Asthma Proc; 2009; 30(5):493-9. PubMed ID: 19843403
[TBL] [Abstract][Full Text] [Related]
6. Content validity of visual analog scales to assess symptom severity of acute angioedema attacks in adults with hereditary angioedema: an interview study.
McMillan CV; Speight J; Relan A; Bellizzi L; Haase G; Cicardi M
Patient; 2012; 5(2):113-26. PubMed ID: 22462765
[TBL] [Abstract][Full Text] [Related]
7. Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema.
Cao Y; Liu S; Zhi Y
Allergy Asthma Proc; 2021 Mar; 42(2):131-135. PubMed ID: 33685557
[No Abstract] [Full Text] [Related]
8. Many faces of angioedema: focus on the diagnosis and management of abdominal manifestations of hereditary angioedema.
Nzeako UC; Longhurst HJ
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):353-61. PubMed ID: 22410711
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported burden of hereditary angioedema: findings from a patient survey in the United States.
Banerji A; Davis KH; Brown TM; Hollis K; Hunter SM; Long J; Jain G; Devercelli G
Ann Allergy Asthma Immunol; 2020 Jun; 124(6):600-607. PubMed ID: 32169514
[TBL] [Abstract][Full Text] [Related]
10. Effect of COVID-19 on hereditary angioedema activity and quality of life.
Can Bostan O; Tuncay G; Damadoglu E; Karakaya G; Kalyoncu AF
Allergy Asthma Proc; 2021 Sep; 42(5):403-408. PubMed ID: 34474710
[No Abstract] [Full Text] [Related]
11. Consider Hereditary Angioedema in the Differential Diagnosis for Unexplained Recurring Abdominal Pain.
Staller K; Lembo A; Banerji A; Bernstein JA; Shah ED; Riedl MA
J Clin Gastroenterol; 2022 Oct; 56(9):740-747. PubMed ID: 35960533
[TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan.
Ohsawa I; Honda D; Nagamachi S; Hisada A; Shimamoto M; Inoshita H; Mano S; Tomino Y
Ann Allergy Asthma Immunol; 2015 Jun; 114(6):492-8. PubMed ID: 25872948
[TBL] [Abstract][Full Text] [Related]
13. New Instrument for the Evaluation of Prodromes and Attacks of Hereditary Angioedema (HAE-EPA).
Leibovich-Nassi I; Golander H; Somech R; Har-Even D; Reshef A
Clin Rev Allergy Immunol; 2021 Aug; 61(1):29-39. PubMed ID: 33538950
[TBL] [Abstract][Full Text] [Related]
14. Dedicated call center (SOS-HAE) for hereditary angioedema attacks: study protocol for a randomised controlled trial.
Javaud N; Fain O; Durand-Zaleski I; Launay D; Bouillet L; Gompel A; Sobel A; Woimant M; Rabetrano H; Petrovic T; Lapostolle F; Boccon-Gibod I; Reuter PG; Bertrand P; Coppere B; Floccard B; Kanny G; Martin L; Vicaut E; Adnet F
Trials; 2016 Apr; 17(1):225. PubMed ID: 27140403
[TBL] [Abstract][Full Text] [Related]
15. The Enigma of Prodromes in Hereditary Angioedema (HAE).
Leibovich-Nassi I; Reshef A
Clin Rev Allergy Immunol; 2021 Aug; 61(1):15-28. PubMed ID: 33534063
[TBL] [Abstract][Full Text] [Related]
16. Current characteristics associated with hereditary angioedema attacks and treatment: the home infusion based patient experience.
Tachdjian R; Banerji A; Guyer A; Morphew T
Allergy Asthma Proc; 2015; 36(2):151-9. PubMed ID: 25715244
[TBL] [Abstract][Full Text] [Related]
17. Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.
Bonner N; Abetz-Webb L; Renault L; Caballero T; Longhurst H; Maurer M; Christiansen S; Zuraw B;
Health Qual Life Outcomes; 2015 Jul; 13():92. PubMed ID: 26129930
[TBL] [Abstract][Full Text] [Related]
18. Ecallantide for treatment of acute hereditary angioedema attacks: analysis of efficacy by patient characteristics.
MacGinnitie AJ; Campion M; Stolz LE; Pullman WE
Allergy Asthma Proc; 2012; 33(2):178-85. PubMed ID: 22525395
[TBL] [Abstract][Full Text] [Related]
19. Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.
Nordenfelt P; Dawson S; Wahlgren CF; Lindfors A; Mallbris L; Björkander J
Allergy Asthma Proc; 2014; 35(2):185-90. PubMed ID: 24411585
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.
Li HH; Moldovan D; Bernstein JA; Reshef A; Porebski G; Stobiecki M; Baker J; Levy R; Relan A; Riedl M
J Allergy Clin Immunol Pract; 2015; 3(3):417-23. PubMed ID: 25680925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
